Results 1 to 10 of about 28,708 (180)

A Peptide from Budding Yeast GAPDH Serves as a Promising Antifungal against Cryptococcus neoformans

Microbiology Spectrum, 2022
Infection of Cryptococcus neoformans is one of the leading causes of morbidity and mortality, particularly among immunocompromised patients. However, currently available drugs for the treatment of C. neoformans infection are minimal. Here, we report SP1,
Yang Zhang, Liyan Zhou, Yan Liu, Xi Zhao, Xianqiang Lian, Jie Zhang, De Zhao, Yujuan Wang, Jin Zhong, Junfeng Wang, Hongli Wang, Linqi Wang, Yu V. Fu   +12 more
doaj   +1 more source

Cryptococcus neoformans

Emerging Infectious Diseases, 2008
doaj   +4 more sources

Pigment production on L-tryptophan medium by Cryptococcus gattii and Cryptococcus neoformans. [PDF]

PLoS ONE, 2014
In recent years strains previously grouped within Cryptococcus neoformans have been divided into two species C. neoformans and C. gattii, with Cryptococcus neoformans comprising serotypes A, D, and AD and C.
Stuart Chaskes, Michael Cammer, Edward Nieves, Arturo Casadevall   +3 more
doaj   +1 more source

Melanogenesis in Cryptococcus neoformans [PDF]

Microbiology, 1988
Melanogenesis in Cryptococcus neoformans begins with the oxidation of dihydroxyphenylalanine by the enzyme phenol oxidase. The succeeding steps are very rapid. Two intermediates, dopachrome and 5,6-dihydroxyindole, have been isolated and characterized by high performance liquid chromatography. A pathway of melanin formation in C. neoformans is proposed,
I, Polacheck, K J, Kwon-Chung
openaire   +2 more sources

Cryptococcus neoformans and Other Opportunistic Cryptococcus Species in Pigeon Dropping in Saudi Arabia: Identification and Characterization by DNA Sequencing

Frontiers in Microbiology, 2021
The prevalent variants of Cryptococcus neoformans, and other Cryptococcus species in pigeon excreta in Western Region of Saudi Arabia were studied.
Bashir Sirag, El-Shiekh Khidir, Mohammed Dumyati, Basam Sindi, Mahir Alsinnari, Hani Faidah, Abdalla Ahmed   +6 more
doaj   +1 more source

Galactoxylomannans of Cryptococcus neoformans [PDF]

Infection and Immunity, 1992
Galactoxylomannans (GalXMs) from single isolates of Cryptococcus neoformans serotypes A, B, and D were isolated from culture supernatants and then purified by affinity, ion-exchange, and gel-filtration chromatography. GalXMs are a group of closely related complex polysaccharides.
P G, James, R, Cherniak
openaire   +2 more sources

Concurrent Pulmonary and Cerebellar Cryptococcus Gattii Cryptococcoma in an Apparently Immunocompetent Patient in Florida

Case Reports in Infectious Diseases, 2021
Cryptococcus infection is caused by one of the two species, Cryptococcus neoformans, or the less common Cryptococcus gattii. While Cryptococcus neoformans commonly infects the immunocompromised population, Cryptococcus gattii has been seen more ...
Benjamin Billings, Neeka Akhavan, Amy Vittor, Ying Nagoshi   +3 more
doaj   +1 more source

The capsule ofCryptococcus neoformans [PDF]

Virulence, 2018
The capsule of Cryptococcus neoformans is its dominant virulence factor and plays a key role in the biology of this fungus. In this essay, we focus on the capsule as a cellular structure and note the limitations inherent in the current methodologies available for its study.
Arturo Casadevall, Carolina Coelho, Radames J. B. Cordero, Quigly Dragotakes, Eric Jung, Raghav Vij, Maggie P. Wear   +6 more
openaire   +3 more sources

Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis. [PDF]

PLoS ONE, 2016
Cryptococcus neoformans is an opportunistic fungal pathogen and the causative agent of the disease cryptococcosis. Cryptococcosis is initiated as a pulmonary infection and in conditions of immune deficiency disseminates to the blood stream and central ...
Visesato Mor, Amir M Farnoud, Ashutosh Singh, Antonella Rella, Hiromasa Tanno, Keiko Ishii, Kazuyoshi Kawakami, Toshiya Sato, Maurizio Del Poeta   +8 more
doaj   +1 more source

Primeira descrição da caracterização fenotípica e susceptibilidade in vitro a drogas de leveduras do gênero Cryptococcus spp isoladas de pacientes HIV positivos e negativos, Estado de Mato Grosso First description of phenotypic profile and in vitro drug susceptibility of Cryptococcus spp yeast isolated from HIV-positive and HIV-negative patients in State of Mato Grosso

Revista da Sociedade Brasileira de Medicina Tropical, 2009
Foram avaliados 37 isolados de 10 pacientes HIV negativos e 26 positivos, em Mato Grosso. Exame direto, cultura e quimiotipagem de espécies foram realizados. Cetoconazol, itraconazol, voriconazol, fluconazol e anfotericina B foram avaliados.
Olivia Cometti Favalessa, Luciano Correa Ribeiro, Tomoko Tadano, Cor Jesus Fernandes Fontes, Flávio Basili Dias, Bruno Pereira Albuquerque Coelho, Rosane Christine Hahn   +6 more
doaj   +1 more source